Etiopathology study of Shvitra(Vitiligo) and Therapeutic uses of Dhatri Khadiradi Yog

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/035085

Enrollment

Registered

2021-07-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

Intervention1: Dhatri khadiradi yog: Dhatri khadiradi yog with bakuchi 30ml twice in a day after meal for 20 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pateint willing to give consent for clinical trail. 2.Pateint having any clinical sign and symptoms of Shivitra(vitiligo) 3.Pateint having chronicity less than 5years.

Exclusion criteria

Exclusion criteria: 1.Patient with age group of less than 18 years and more than 60 years. 2.White anesthetic spots, which are characteristic of leprosy. 3.Patches in genital area will be excluded from the study. 4.Vitiligo patches complicated with eczema. 5.Patients with evidence of malignancy, diabetes mellitus with complication, albinism. 6.Pregnant women and lactating mother. 7.Patient participated in any clinical trial within last six months.

Design outcomes

Primary

Measure	Time frame
changes in sign and symptoms of shvitra(vitiligo).Timepoint: 60 Days	—

Secondary

Measure	Time frame
Changes in shvitra (vitiligo) grading score.Timepoint: 60 Days	—

Countries

India

Contacts

Public ContactDr Zeiba Khan

Madan mohan malviya govt ayurved college

pankajmarolia@gmail.com9413193101

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026